The FDA has approved Thermo Fisher’s Oncomine Dx Target Test, a next-generation sequencing based companion diagnostic, to ...

Researchers at Weill Cornell Medicine have made a breakthrough in the fight against liver cancer, by identifying a biomarker ...

The use of engineered viruses in cancer treatment is gaining significant traction, offering new avenues for enhancing immune ...

Sanofi and Orano Med have partnered to accelerate the development of next-generation radioligand therapies for rare cancers, ...

Developed by AI, Lantern Pharma's investigational drug LP-184 has received FDA Fast-Track Designation for glioblastoma.

The FDA has approved zolbetuximab-clzb (VYLOY) as a first-line targeted therapy, in combination with chemotherapy, for the ...

The Merlin test (CP-GEP), a molecular diagnostic tool developed by SkylineDx, significantly reduces the need for sentinel ...

The FDA has approved Genentech’s Itovebi™ (inavolisib) as a targeted therapy for adults with advanced hormone ...